Controlled drug delivery systems for cancer based on mesoporous silica nanoparticles

Nerea Iturrioz-Rodríguez,1 Miguel A Correa-Duarte,2,3 Mónica L Fanarraga11Nanomedicine Group, University of Cantabria – IDIVAL, Santander, 39011, Spain; 2Department of Physical Chemistry, Center for Biomedical Research (CINBIO), Southern Galicia Institute of Health Re...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Iturrioz-Rodríguez N, Correa-Duarte MA, Fanarraga ML
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2019
Materias:	Nanocarrier drug release targeted drug delivery biocompatibility biodegradability tumour. Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/03e90c363e6442f19896e2f2f95734d0
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:03e90c363e6442f19896e2f2f95734d0
record_format	dspace
spelling	oai:doaj.org-article:03e90c363e6442f19896e2f2f95734d02021-12-02T07:33:01ZControlled drug delivery systems for cancer based on mesoporous silica nanoparticles1178-2013https://doaj.org/article/03e90c363e6442f19896e2f2f95734d02019-05-01T00:00:00Zhttps://www.dovepress.com/controlled-drug-delivery-systems-for-cancer-based-on-mesoporous-silica-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Nerea Iturrioz-Rodríguez,1 Miguel A Correa-Duarte,2,3 Mónica L Fanarraga11Nanomedicine Group, University of Cantabria – IDIVAL, Santander, 39011, Spain; 2Department of Physical Chemistry, Center for Biomedical Research (CINBIO), Southern Galicia Institute of Health Research (IISGS), Vigo 36310, Spain; 3Biomedical Research Networking Center for Mental Health (CIBERSAM), Universidade de Vigo, Vigo 36310, SpainAbstract: The implementation of nanotechnology in medicine has opened new research horizons particularly in the field of therapeutic delivery. Mesoporous silica particles have emerged as biocompatible drug delivery systems with an enormous potential in the treatment of cancer among many other pathologies. In this review, we focus on the unique properties of these particles as chemotherapy delivery carriers. Here, we summarize the general characteristics of these nanomaterials – including their physicochemical properties and customizable surfaces – different stimuli that can be used to trigger targeted drug release, biocompatibility and finally, the drawbacks of these types of nanomaterials, highlighting some of the most important features of mesoporous silica nanoparticles in drug delivery.Keywords: nanocarrier, drug release, targeted drug delivery, biocompatibility, biodegradability, tumorIturrioz-Rodríguez NCorrea-Duarte MAFanarraga MLDove Medical PressarticleNanocarrierdrug releasetargeted drug deliverybiocompatibilitybiodegradabilitytumour.Medicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 14, Pp 3389-3401 (2019)
institution	DOAJ
collection	DOAJ
language	EN
topic	Nanocarrier drug release targeted drug delivery biocompatibility biodegradability tumour. Medicine (General) R5-920
spellingShingle	Nanocarrier drug release targeted drug delivery biocompatibility biodegradability tumour. Medicine (General) R5-920 Iturrioz-Rodríguez N Correa-Duarte MA Fanarraga ML Controlled drug delivery systems for cancer based on mesoporous silica nanoparticles
description	Nerea Iturrioz-Rodríguez,1 Miguel A Correa-Duarte,2,3 Mónica L Fanarraga11Nanomedicine Group, University of Cantabria – IDIVAL, Santander, 39011, Spain; 2Department of Physical Chemistry, Center for Biomedical Research (CINBIO), Southern Galicia Institute of Health Research (IISGS), Vigo 36310, Spain; 3Biomedical Research Networking Center for Mental Health (CIBERSAM), Universidade de Vigo, Vigo 36310, SpainAbstract: The implementation of nanotechnology in medicine has opened new research horizons particularly in the field of therapeutic delivery. Mesoporous silica particles have emerged as biocompatible drug delivery systems with an enormous potential in the treatment of cancer among many other pathologies. In this review, we focus on the unique properties of these particles as chemotherapy delivery carriers. Here, we summarize the general characteristics of these nanomaterials – including their physicochemical properties and customizable surfaces – different stimuli that can be used to trigger targeted drug release, biocompatibility and finally, the drawbacks of these types of nanomaterials, highlighting some of the most important features of mesoporous silica nanoparticles in drug delivery.Keywords: nanocarrier, drug release, targeted drug delivery, biocompatibility, biodegradability, tumor
format	article
author	Iturrioz-Rodríguez N Correa-Duarte MA Fanarraga ML
author_facet	Iturrioz-Rodríguez N Correa-Duarte MA Fanarraga ML
author_sort	Iturrioz-Rodríguez N
title	Controlled drug delivery systems for cancer based on mesoporous silica nanoparticles
title_short	Controlled drug delivery systems for cancer based on mesoporous silica nanoparticles
title_full	Controlled drug delivery systems for cancer based on mesoporous silica nanoparticles
title_fullStr	Controlled drug delivery systems for cancer based on mesoporous silica nanoparticles
title_full_unstemmed	Controlled drug delivery systems for cancer based on mesoporous silica nanoparticles
title_sort	controlled drug delivery systems for cancer based on mesoporous silica nanoparticles
publisher	Dove Medical Press
publishDate	2019
url	https://doaj.org/article/03e90c363e6442f19896e2f2f95734d0
work_keys_str_mv	AT iturriozrodriguezn controlleddrugdeliverysystemsforcancerbasedonmesoporoussilicananoparticles AT correaduartema controlleddrugdeliverysystemsforcancerbasedonmesoporoussilicananoparticles AT fanarragaml controlleddrugdeliverysystemsforcancerbasedonmesoporoussilicananoparticles
_version_	1718399319014375424

Controlled drug delivery systems for cancer based on mesoporous silica nanoparticles

Ejemplares similares